Dementia and Depression with Ischemic Heart Disease: A Population-Based Longitudinal Study Comparing Interventional Approaches to Medical Management
2011

Dementia and Depression in Ischemic Heart Disease Patients: A Study of Treatment Approaches

Sample size: 34508 publication 10 minutes Evidence: moderate

Author Information

Author(s): Mutch W. Alan C., Fransoo Randall R., Campbell Barry I., Chateau Dan G., Sirski Monica, Warrian R. Keith

Primary Institution: University of Manitoba

Hypothesis

Does the type of treatment for ischemic heart disease (IHD) affect the likelihood of developing dementia and depression?

Conclusion

Patients managed with PCI had a lower likelihood of dementia compared to those receiving medical management alone, while both PCI and CABG were associated with a higher risk of new depression.

Supporting Evidence

  • Patients managed with PCI had a 65% lower risk of dementia compared to medical management.
  • New depression was more frequent in patients undergoing PCI and CABG compared to those receiving medical management.
  • The study followed patients for a minimum of three years and up to eight years after their diagnosis of IHD.

Takeaway

This study found that patients who had a procedure called PCI were less likely to get dementia compared to those who just took medicine for their heart problems, but both types of surgery increased the chances of feeling depressed.

Methodology

The study analyzed health service records of IHD patients in Manitoba, Canada, comparing outcomes of dementia and depression across three treatment groups: PCI, CABG, and medical management.

Potential Biases

Potential misdiagnosis of dementia as depression and the observational nature of the study may introduce bias.

Limitations

The study relied on administrative data, which may not accurately capture all cases of dementia and depression, particularly milder forms.

Participant Demographics

Participants were residents of Manitoba, Canada, aged 40 years or older, with a diagnosis of ischemic heart disease.

Statistical Information

P-Value

0.017

Confidence Interval

95% CI: 0.46 to 0.84

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0017457

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication